Diagnosis and treatment frequency for overweight children and adolescents at well child visits

Miriam V Louthan1, Margaret J Lafferty-Oza, Elizabeth R Smith

  • 1Department of Pediatrics, University of Louisville/School of Medicine, Louisville, KY 40202, USA.

Clinical Pediatrics
|January 29, 2005
PubMed

Insights

Pediatricians critically underdiagnose childhood obesity. In a study of well-child visits, only 29% of overweight children were correctly identified, highlighting a significant gap in recognizing this growing health concern.

Area of Science:

  • Pediatric Health
  • Public Health
  • Childhood Obesity Research

Background:

  • Childhood obesity is a significant and escalating global health issue.
  • Underrecognition of overweight and obesity by healthcare providers may impede timely intervention.

Purpose of the Study:

  • To evaluate the accuracy of pediatricians in diagnosing overweight children during routine well-child visits.
  • To determine the frequency of correct identification of pediatric overweight status.

Main Methods:

  • A retrospective review of 473 consecutive well-child visits was conducted.
  • Physician diagnoses were compared against body mass index (BMI) percentiles for age and gender.

Main Results:

  • Only 27 out of 473 children (29%) with a BMI above the 95th percentile were diagnosed as overweight by their physicians.
  • This indicates a low rate of accurate diagnosis for pediatric overweight during routine care.

Conclusions:

  • The current frequency of diagnosing overweight children in well-child visits is critically low.
  • Improved clinical awareness and diagnostic practices are needed to address pediatric obesity effectively.

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...